Recent Finacing
Recent Raise
QureBio develops bispecific and multispecific antibody and protein therapeutics using proprietary I2T, T‑cell and NK‑cell engager platforms, advancing multiple clinical-stage candidates across China and the US.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at QureBio.
